272 related articles for article (PubMed ID: 14615375)
1. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
Tiwari S; Felekkis K; Moon EY; Flies A; Sherr DH; Lerner A
Blood; 2004 Apr; 103(7):2661-7. PubMed ID: 14615375
[TBL] [Abstract][Full Text] [Related]
2. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
3. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
[TBL] [Abstract][Full Text] [Related]
5. PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A.
Moon EY; Lerner A
Blood; 2003 May; 101(10):4122-30. PubMed ID: 12531792
[TBL] [Abstract][Full Text] [Related]
6. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
Kim DH; Lerner A
Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
[TBL] [Abstract][Full Text] [Related]
7. Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells.
Moon EY; Oh SY; Han GH; Lee CS; Park SK
J Neurosci Res; 2005 Jul; 81(1):38-44. PubMed ID: 15931667
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells.
Meyers JA; Taverna J; Chaves J; Makkinje A; Lerner A
Clin Cancer Res; 2007 Aug; 13(16):4920-7. PubMed ID: 17699872
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
10. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK.
Enserink JM; Christensen AE; de Rooij J; van Triest M; Schwede F; Genieser HG; Døskeland SO; Blank JL; Bos JL
Nat Cell Biol; 2002 Nov; 4(11):901-6. PubMed ID: 12402047
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
Rangarajan S; Enserink JM; Kuiperij HB; de Rooij J; Price LS; Schwede F; Bos JL
J Cell Biol; 2003 Feb; 160(4):487-93. PubMed ID: 12578910
[TBL] [Abstract][Full Text] [Related]
12. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation.
Misra UK; Pizzo SV
J Biol Chem; 2005 Nov; 280(46):38276-89. PubMed ID: 16172130
[TBL] [Abstract][Full Text] [Related]
13. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R
J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990
[TBL] [Abstract][Full Text] [Related]
14. Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation.
Wang Z; Dillon TJ; Pokala V; Mishra S; Labudda K; Hunter B; Stork PJ
Mol Cell Biol; 2006 Mar; 26(6):2130-45. PubMed ID: 16507992
[TBL] [Abstract][Full Text] [Related]
15. ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages.
Moon EY; Lee JH; Lee JW; Song JH; Pyo S
Cell Signal; 2011 Sep; 23(9):1479-88. PubMed ID: 21596132
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC
Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746
[TBL] [Abstract][Full Text] [Related]
18. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages.
Bryn T; Mahic M; Enserink JM; Schwede F; Aandahl EM; Taskén K
J Immunol; 2006 Jun; 176(12):7361-70. PubMed ID: 16751380
[TBL] [Abstract][Full Text] [Related]
19. Rap1 activation plays a regulatory role in pancreatic amylase secretion.
Sabbatini ME; Chen X; Ernst SA; Williams JA
J Biol Chem; 2008 Aug; 283(35):23884-94. PubMed ID: 18577515
[TBL] [Abstract][Full Text] [Related]
20. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis.
Omar B; Zmuda-Trzebiatowska E; Manganiello V; Göransson O; Degerman E
Cell Signal; 2009 May; 21(5):760-6. PubMed ID: 19167487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
